This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. Policy Advocacy: Supporting Prevention on a Broader Scale Publichealth policies to reduce environmental risk factors (e.g.,
In recent years, the incidence of cardiovascular disease (CVD) has risen steadily, significantly impacting publichealth. Evidence suggests SCH may exacerbate atherosclerosis and cardiac dysfunction through mechanisms such as increased LDL synthesis, oxidative stress, and impaired vascular endothelial function.
This event encompasses various facets, including publichealth, primary care, secondary prevention, rehabilitation, sports cardiology, and exercise. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease.
This event encompasses various facets, including publichealth, primary care, secondary prevention, rehabilitation, sports cardiology, and exercise. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease. Hashtag: #ICNCCT2024 7.
The AHA strives to further understand and help heal health problems inflicted by structural racism, a publichealth crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives.
School of PublicHealth at UT Southwestern. guidelines may overlook people who are at higher risk of developing atherosclerosis despite normal metabolic health markers. The study includes an online calculator for the public to estimate apoB levels based on the LDL-C level. Physicians following U.S.
The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and publichealth advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and publichealth advocates.
MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. THE UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE'S CLINT L.
ICYMI On Wednesday, I published a post about the recent evidence on high-volume exercise and atherosclerosis in athletes. Physiologically Speaking is a reader-supported publication. .” Getting more people to exercise more has been a goal of exercise scientists and publichealth experts for decades.
In the study, the researchers examined the performance of established primary-prevention risk predictors in an existing dataset covering 9,138 participants from a long-term study called the Atherosclerosis Risk in Communities study ( ARIC ).
PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. Racial and ethnic disparities in the detection, management and health outcomes of PAD have long been present in the U.S. and are an important publichealth issue to be addressed,” said Gornik.
BackgroundSudden cardiac death (SCD) is a significant global publichealth problem accounting for 15% to 20% of all deaths. The ankle–brachial index (ABI) is a simple, noninvasive measure of subclinical atherosclerosis. A great majority of SCD is associated with coronary heart disease, which may first be detected at autopsy.
2 Air pollution has been referred to as “the single most important environmental factor presenting a risk to health and represents a greater disease burden than polluted water, soil contamination and occupational exposures combined”. Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide, causing around 17.9
Kenton III Lecture Award, is the director and founding dean of the University of California, Irvine’s Program in PublicHealth and future School of Population and PublicHealth. the winner of the Edgar J. The Ralph L.
Since 2010, HIV-related deaths have been reduced by 51%, but HIV continues to be a major global publichealth issue, claiming 40.4 million lives so far.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content